Acknowledgements


Appendix D, Answers to Warm-Up Questions and Case Studies



Download 1.91 Mb.
Page48/52
Date10.08.2017
Size1.91 Mb.
#31130
1   ...   44   45   46   47   48   49   50   51   52

Appendix D, Answers to Warm-Up Questions and Case Studies

Answers are provided in italics for each unit’s warm-up questions and case study. Answers to the questions within the unit are not included. Unit questions are designed to stimulate small group discussion among participants in the workshop or class.



Unit 1 Answers



Warm-up

questions



  1. True or false? Almost 40 million people worldwide are infected with HIV.

True. UNAIDS estimates that 39.4 million adults and children were living with HIV/AIDS in 2004.



  1. What region of the world has been most affected by HIV/AIDS, with an infection prevalence of over 30% in some countries?

Sub-Saharan Africa. According to UNAIDS, the region is home to 64% of people living with HIV/AIDS worldwide.


  1. Which region of the world has the second-highest HIV prevalence?

The Caribbean is the second-most affected region in the world. In the Caribbean, AIDS is the leading cause of death among adults (15–44 years) and claimed an estimated 27 000 [18 000–37 000] lives in 2005.


  1. What region in the Caribbean has been most affected by HIV/AIDS?

Hispaniola Island, which includes Haiti and the Dominican Republic, is the epicentre of the HIV epidemic in the Americas.


  1. The major factor that accounts for the prevalence rates of HIV/AIDS in the Caribbean is:




    1. injection drug use

  1. homosexual transmission

  2. heterosexual transmission

  3. blood exposure from unsafe medical practises

  4. all of the above

In the Caribbean, the primary mode of sexual transmission has changed from being predominantly homosexual to being a mosaic of homo/bi and heterosexual epidemics. Heterosexual transmission accounts for the majority of HIV/AIDS cases in the Caribbean. Injecting drug use is responsible for a minority of HIV infections and only contributes significantly to the spread of HIV in Bermuda.

Case study

Cariba is a Caribbean nation that had its earliest cases of AIDS recognised in 1986. Data below are based on estimates of HIV prevalence by parish.
HIV prevalence (%) by parish, Cariba, 1995-2002.


Parish

1995

1998

2000

2002

St. Mary

.2

0.5

1.0

1.1

Kingstown

0.5

0.7

0.9

0.8

Arima

1.0

2.0

2.7

2.9

St. James

0.1

0.7

2.8

3.8

Yotown

0.4

0.9

1.3

1.2



    1. What parish has historically had the greatest proportion of its population infected with HIV?

Arima.
b. What are prominent recent trends?

Prominent recent trends are: continued slow growth in St. Mary and Arima, levelling off or decrease in Kingstown and Yotown and rapid growth in St. James.


  1. In 2002, which parish had the highest prevalence? Is the epidemic increasing or decreasing in this parish?

St. James. The epidemic is increasing rapidly.
Unit 2 Answers
Warm-up

questions




        1. Which body cells does HIV infect?

    1. respiratory cells

    2. skin cells

    3. red blood cells

    4. white blood cells

HIV infects white blood cells, which are involved with protecting the body against infection as part of the immune system. These include lymphocytes and macrophages.
2. How many major strains of HIV exist?

Two: HIV-1 and HIV-2.


  1. Which of the following is not a method of HIV transmission?

  1. sexual intercourse

  2. casual physical contact

  3. blood exchange

  4. mother-to-foetus transmission

HIV transmission is transmitted through body fluids, not through casual physical contact.


  1. What type of infectious agent is HIV?

  1. bacterium

  2. virus

  3. prion

  4. none of the above

HIV is a virus. HIV stands for ‘human immunodeficiency virus.’


  1. True or false? HIV infection and the onset of AIDS occur simultaneously.

True False

False. AIDS is characterised by the clinical appearance of symptoms. It can occur years after the initial HIV infection.


  1. Which region of the world has the greatest diversity of HIV sub-types, making the development of one unique treatment or vaccine difficult?

Sub-Saharan Africa has the greatest diversity of HIV sub-types. This region has not only the highest HIV prevalence levels, but also the greatest diversity of sub-types, making treatment especially difficult.
Warm-up questions, continued



  1. Which of the following is associated with increased risk of sexual transmission of HIV?

    1. failure to use a male or female condom

    2. a greater number of sexual partners

    3. a high viral load in an infected partner

    4. all of the above

The failure to use a condom allows the virus to pass more easily from an infected to an uninfected person. The more sexual partners an individual has, the higher the risk that the one of them is infected with HIV. A greater amount of virus in the bodily fluids increases the chances that the virus will be transmitted to the uninfected partner.


  1. True or false? The presence of existing sexually transmitted infections (STIs) increases the risk of acquiring HIV during sexual intercourse.


True False

True. The inflammation and ulceration caused by existing STIs makes it easier for HIV to enter the body.



  1. List the three main types of antiretroviral drugs used to treat HIV infection.

  1. nucleoside reverse transcriptase inhibitors (NRTIs)

  2. non-nucleoside reverse transcriptase inhibitors (nNRTIs)

  3. protease inhibitors (PIs)




  1. Which of the following fatal opportunistic infections commonly occur(s) in AIDS patients?

    1. herpes zoster

    2. fungal infections

    3. tuberculosis (TB)

    4. all of the above

AIDS patients have weaker immune systems, making it easier for the patients to acquire these opportunistic infections.


  1. True or false? A vaccine for the prevention of HIV infection is currently available.

True False

False. While vaccines are being researched and may be available many years in the future, currently there is no HIV vaccine.


  1. True or false? Some STIs, such as chlamydia, are biologically more easily acquired by young women, making them more susceptible to HIV infection.

True False

Warm-up questions, continued
True. Because of their more fragile vaginal walls, young women are more likely to be infected.


  1. Prophylaxis is the term used to describe the treatment to prevent or suppress infection.

Prophylaxis helps to prevent opportunistic infections from developing in patients with HIV infection.
Case study

Cariba has experienced rapid expansion of the HIV epidemic. Prevention programmes to date have focused primarily on prevention of mother-to-child transmission. Examine the data and answer the questions.


Incidence of various STIs over time, Cariba.





2000

2001

2002

Gonorrhoea*

5.0

12.8

23.5

Syphilis*

2.1

4.5

16.4

Reported cases of urethritis from STI clinic

2 987

3 452

6 784

HIV incidence (estimated)

2.0%

4.3%

5.0%

* Cases per 1000, population 15-49 years
a. Do you think that sexually transmitted infections (STIs) may be playing an important role in the spread of HIV infection? Why?

Yes, it is likely that STIs are playing a major role in the spread of sexually transmitted HIV in Cariba. It’s likely that STIs are important in HIV transmission because:

      • rates of STIs are high and increasing

      • prevalence of HIV is relatively low and incidence is rising.

This is a classic exponential growth phase and similar to the situation in Mwanza, Tanzania, where STI control was able to show an effect on HIV incidence.

b. Would an STI prevention programme be an important part of the country’s HIV control efforts?



Yes, these data suggest that a situation similar to that in Mwanza, Tanzania exists in Cariba. An enhanced STI control programme may be critical to decreasing HIV incidence.

Warm-up questions, continued
c. Given the HIV incidence in Cariba, what do you think will happen to tuberculosis rates in the next several years, and why?

Tuberculosis (TB) rates will likely increase as the HIV epidemic spreads. TB cases will involve both the appearance of active tuberculosis among persons already infected with TB, and transmission of TB from HIV-infected persons to those with and without HIV infection.

Unit 3 Answers
Warm-up

questions



  1. Which of the following terms indicates the number or proportion of persons in a population who have a disease at a given point in time?




    1. sensitivity

    2. prevalence

    3. negative predictive value

    4. none of the above

Prevalence is a measure of disease burden in a given population, while sensitivity and negative predictive value are terms used to describe the validity of case definitions.


  1. True or false? One-time cross-sectional surveys are valid methods of HIV/AIDS surveillance.

True False

False. Surveillance systems involve ongoing collection and analysis of data, not a one-time survey.


  1. Match the following terms with their definitions:




_a_ laboratory-based reporting

a. surveillance system in which the reports of cases come from clinical laboratories, as opposed to healthcare practitioners or hospitals

_b_ case definition

b. the clinical and laboratory characteristics that a patient must have to be counted as a case for surveillance purposes




  1. Which of the following terms indicates the number of persons who develop a disease within a specified time period?




    1. specificity

    2. positive predictive value

    3. incidence

    4. none of the above

Incidence is the rate at which disease burden is increasing in a particular population, while specificity and positive predictive value are terms used to describe case definitions.

Unit 4 Answers
4.1 Warm-up

questions


1. What are the key differences between HIV sero-surveillance and HIV case reporting?

HIV sero-surveillance refers to the component of second-generation HIV surveillance that measures HIV prevalence. HIV sero-surveillance measures HIV prevalence in specific populations on a regular basis using sero-surveys. HIV case reporting refers to the process of reporting the names or codes of persons with confirmed HIV positive status to surveillance staff.



  1. True or false? HIV testing of women coming in for antenatal care is a component of HIV case reporting.

True False

True. HIV testing of women attending antenatal clinics has been the most frequently used data for prevalence estimates.



  1. Which of the following is NOT a purpose of advanced HIV disease/AIDS case reporting?

  1. to determine the burden of disease attributable to advanced HIV disease/AIDS in the region

  2. to assess trends in advanced HIV disease/AIDS cases

  3. to provide information on the opportunistic infections associated with cases of advanced HIV disease

  4. to measure HIV incidence

AIDS has a long latent period before symptoms are clinically apparent. Advanced HIV disease/AIDS case reporting does not measure incidence of HIV infection.


  1. List five key measures that target points for HIV surveillance.




  1. HIV incidence (that is, the number or rate of new HIV infections)

  2. HIV prevalence (that is, the number or rate of all persons living with HIV, regardless of how long they have been infected and whether or not they are aware of their infection)

  3. The incidence of advanced HIV disease (or AIDS)

  4. The prevalence of advanced HIV disease (or AIDS)

  5. Deaths from advanced HIV disease (or AIDS)

4.1 Warm-up questions, continued





  1. To capture the leading edge of the epidemic

  1. To provide a complete count or estimate of the number of persons with HIV infection, because AIDS case reporting does not include asymptomatic HIV-infected persons

  2. As a way to measure the effectiveness of treatment programmes and other interventions.




  1. Which stage in the life cycle of HIV requires use of special (not routine) laboratory tests to measure?

Special laboratory tests are required to detect HIV incidence. The BED assay is a promising technique to measure HIV incidence in a single blood specimen. The BED assay identifies persons who were infected in the last 160 days (or nearly six months.)
4.1 Case study

1. You are the parish surveillance officer in Cariba, which is estimated to have one of the highest prevalence rates of HIV in the region. The national AIDS control programme is interested in expanding and improving its surveillance programme, and the national surveillance officer is conducting site visits to various parishes to discuss ways of improving surveillance. During your meeting with the national surveillance officer, you are asked to suggest additional surveillance activities in your parish that you believe could be implemented successfully. Describe the activities you would suggest.


Additional surveillance activities that could be successfully implemented to expand the AIDS control programme surveillance system include: using data from HIV testing and prevention of mother-to-child programmes to count asymptomatic HIV cases; using data from treatment and care programmes to supplement HIV case surveillance data.


  1. The national surveillance officer has indicated that there is interest in using data collected from care programmes, including HIV care programmes, for HIV case reporting. What programmes would you suggest using?


Antiretroviral treatment programme data can provide patient monitoring data. Data from ART programmes can also be used to measure the effectiveness of treatment programmes and other interventions. For efficient use of time and resources, those programmes that serve the largest number of HIV-infected persons should be targeted for assisting with case reporting.
4.2 Warm-up

questions



  1. True or false? In the revised (2006) adult and paediatric WHO HIV clinical staging systems, there are four clinical stages.


True False

True. The revised (2006) adult and paediatric WHO HIV clinical staging systems both include four clinical stages, with stage 1 representing early disease and stage 4 representing late-stage disease (AIDS). For surveillance purposes, stages 3 and 4 meet the criteria for reporting.


  1. True or false? The revised (2006) WHO case definition for advanced HIV disease is the same for adults and infants.


True False

False. Adults and infants may have different clinical manifestations of advanced HIV disease. Also, serologic evidence of immuno-suppression differs between adults and infants. Brief case definitions of advanced HIV disease are provided below.
For adults, the case definition for advanced HIV disease is:

A positive HIV antibody test

AND EITHER

Any clinical stage 3 or stage 4 disease

OR

Where CD4 testing is available, any clinical stage and CD4 count < 350 cells/mm3.
For infants, the case definition for advanced HIV disease is:

The presence of HIV infection

AND EITHER

Any clinical stage 3 or stage 4 disease

OR

Where CD4 testing is available, any clinical stage with

CD4 <20% TLC in children aged 12-59 months.



  1. List the three options for HIV reporting that WHO recommends.

WHO recommends that countries standardise their reporting practises.

Countries may:

  • report all HIV cases (clinical stages 1-4)

  • report advanced HIV disease (clinical stages 3 and 4)

  • report AIDS cases (clinical stage 4).

4.2 Warm-up questions, continued





  1. True or false? The clinical criteria included in the revised (2006) WHO advanced HIV infection surveillance case definition only include definitive diagnoses of clinical events.

True False



The revised case definitions include both presumptive clinical diagnoses that can be made in the absence of sophisticated laboratory tests and definitive clinical criteria that require confirmatory laboratory tests.


  1. List four reasons why HIV clinical staging systems were developed.

  1. to provide uniformity for clinical evaluation of persons with HIV infection

  2. to provide an indicator of prognosis

  3. to guide clinical management of patients

  4. to help study the natural history of HIV infection.




  1. True or false? Previous surveillance case definitions in developing countries focused only on stage 4 (AIDS).


True False

True. Prior to 1994, the WHO had not developed a surveillance case definition for HIV disease alone (that is, persons who have HIV infection but who do not meet the surveillance case definition of AIDS).

Unit 4.2

Case study


  1. As an HIV surveillance officer for Cariba, you are charged with standardising the country’s HIV reporting practises. What processes would you implement to ensure that HIV case-based reporting is standardised?

Processes to ensure that HIV surveillance is standardised include:

  • standardising HIV case definitions for surveillance purposes

  • using a standardised case report form

  • defining the minimum set of information required to report/count a case

  • educating providers regarding reporting requirements, including laws and regulations, case definitions, specific data elements, case report forms, laboratory reports and timeliness of reporting.




  1. Cariba recently began providing free antiretroviral therapy to HIV-infected individuals. The country uses the WHO antiretroviral treatment recommendations to determine the best time to begin antiretroviral therapy.

Unit 4.2 Case study, continued


    1. In St. James Parish, CD4 testing is available. What are the WHO recommendations for when adults and adolescents should begin ART?

If CD4 testing is available, ART can begin at WHO clinical stage 4 (AIDS) regardless of the CD4 count, at WHO clinical stage 3 in patients whose CD4 count is <350 cells/mm3 or in patients with WHO clinical stages 1 or 2 when the CD4 count is < 200 cells/mm3.


    1. In St. Mary Parish CD4 testing is not available. What are the WHO recommendations for when adults and adolescents should begin ART?

If CD4 testing is not available, a total lymphocyte count ≤1200 cells/ mm3 can be used as an indication of immunodeficiency that is severe enough to begin ART.
Unit 4 Final

case study

You are the new HIV programme director in Cariba. Cariba has conducted antenatal sero-surveillance for many years and the results from those surveys have been used to estimate the HIV prevalence in the country. The prevalence in young adults in Cariba is estimated to be 3% in urban areas. HIV case reporting has been recommended, but only a few facilities have reported HIV cases. Because of the high HIV prevalence, it is assumed that the prevalence of AIDS is also very high.


Cariba has received additional resources that are to be used for providing HIV-infected patients with ART. Because of its high prevalence, Yotown County, which has a large urban area, has been selected as a site to offer ART. The provision of ART to HIV-infected patients is co-ordinated by your colleague (Dr. MB) at the Ministry of Health in Cariba. To begin planning for treating patients you set up a meeting with Dr. MB. Together you decide that the initial focus should be on conducting reporting of persons with advanced HIV disease. How would you go about doing this?
In order to determine the number of patients who will need ART, you will need to know the number of patients with advanced HIV disease. (HIV clinical stages 3 and 4.) The clinical/immunological criteria for diagnosing a person with advanced HIV disease are as follows:

Unit 4 Final case study, continued


Category

Clinical/immunological criteria

Advanced HIV in infants, children, adults and adolescents with documented HIV infection

  • Presumptive or definitive diagnosis of any one stage 3 or 4 condition (as defined in annex 2.3 and 2.4).

Children > 6 years, adolescents and adults with documented HIV infection

  • CD4 count less than 350/ mm3.

Children < 6 years with documented HIV infection


  • %CD4 < 30 in those less than 11 months of age

  • %CD4 < 25 in those aged 12–35 months

  • %CD4 < 20 in those aged 35–59 months.


Reporting should be done at the time the person is initially diagnosed with advanced HIV disease.
You and Dr. MB must make decisions regarding how ART should be provided in Yotown Parish. You both agree to follow the WHO treatment guidelines. What are the WHO criteria for initiating ART?

The best time to begin antiretroviral treatment can be determined using clinical staging and, if available, CD4 counts/percents.
The WHO antiretroviral treatment recommendations for adults and adolescents are as follows:


If CD4 testing is:

WHO ART recommendation for adults and adolescents

Available

  • WHO clinical stage 4 (AIDS) regardless of the CD4 count

  • WHO clinical stage 3 when the CD4 count is <350 cells/mm3

  • WHO clinical stages 1 or 2 when the CD4 count is < 200 cells/mm3




Not available

  • WHO clinical stage 4 (AIDS), regardless of total lymphocyte count

  • WHO clinical stage 3, regardless of total lymphocyte count

  • WHO clinical stages 2 with a total lymphocyte count < 1200 cells/mm3





Unit 4 Final case study, continued
You and Dr. MB decide to offer ART at three clinics and at the medical college in Yotown Parish. How will this affect your plans for advanced HIV disease case reporting?

The link between staging, ART use and case reporting is useful for surveillance purposes. HIV case reporting is generally done by healthcare providers, usually from hospitals and clinics that provide ART. Therefore, patients who are receiving care at these facilities will have their clinical stage determined. The clinical/immunological criteria for diagnosing advanced HIV disease correspond to the clinical/immunological criteria for initiating ART.
What are some initial steps that should be taken prior to offering ART?

Prior to offering ART, treatment protocols should be developed;

methods to record patient treatment information should be determined; and staff should be trained. Use of WHO methods is recommended.
What are the outcomes that you think should be monitored in order to evaluate the impact that ART is having on patients with HIV?

In order to determine how well the programme is working, you will need to monitor how many patients initiate ART, what regimens they are receiving, and adherence. To measure the impact that treatment is having, it is best to monitor the development of new opportunistic illnesses and death. Effective treatment programmes should result in declines in both of these.
What methods can be used to measure the impact of ART on mortality?

Ideally, there would be existing mortality data that could be used. If these are not available, then it is worthwhile to develop methods of obtaining census data, deaths, and causes of death using verbal autopsy methods.
Unit 5 Answers

Warm-up


questions

  1. List three aspects of a disease under surveillance that an effective surveillance system should monitor.

In order to describe the condition under surveillance, the surveillance system must be able to describe the condition by the following attributes: person, place and time.


  1. List two methods to measure completeness of case reporting.

  1. Expand surveillance activities to find (and report) any missed cases.

  2. Estimate the proportion of all cases that were reported in a specified time period using a capture-recapture methodology.




  1. List two methods to report the timeliness of case reporting.

To report the timeliness of case reporting you can use:

  1. the median time between diagnosis of HIV or AIDS and receipt of the case report form

  2. the proportion of cases that are received within a specified time period from diagnosis to receipt of report.

Case study

St. James Parish is in the coastal area of Cariba and has the country’s major port city. A British university has been conducting studies of commercial sex workers in the port city for nearly a decade. For the last five years, they have been conducting serial sero-prevalence surveys for HIV and syphilis.
You are the National Surveillance Officer for St. James Parish. You are asked by the Ministry to evaluate these special studies to determine if the Ministry should take over sponsorship of the studies and include them in the provincial sentinel surveillance system.
Now answer the questions below. Look back in the unit for more information if you wish.


  1. How would you start your evaluation?

The first step in evaluating these special studies would be to meet with study staff members and Ministry of Health personnel. The people conducting the special studies and/or the Ministry of Health may want to define the questions to be addressed by the
Case study, continued
surveillance system evaluation. They may also want to decide how to use the findings from the evaluation.


  1. On what would you focus in your evaluation?

As the Ministry of Health is deciding whether or not to take over sponsorship of the studies and include them in the provincial sentinel surveillance system, a possible focus of the evaluation would be to assess how the system can detect and report HIV and syphilis among sex workers and to assess the quality of the epidemiologic information produced.


  1. What criteria would you use to assess the performance of the system?

In a comprehensive evaluation, the simplicity, flexibility, data quality, acceptability, sensitivity, positive predictive value, representativeness, timeliness and stability of the surveillance system should be assessed. CAREC recommends that member countries evaluate the completeness (sensitivity), timeliness and validity of surveillance systems on an annual basis.


  1. What would you recommend?

Although specific recommendations depend on the findings of the assessment, recommendations following an assessment would include: developing strategies for communicating the findings from the evaluation, tailoring the recommendations to relevant audiences, and distributing the results to all partners and sites involved.



Download 1.91 Mb.

Share with your friends:
1   ...   44   45   46   47   48   49   50   51   52




The database is protected by copyright ©ininet.org 2024
send message

    Main page